UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease Journal article
Kosaraju, Jayasankar, Holsinger, R. M. Damian, Guo, Lixia, Tam, Kin Yip. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease[J]. MOLECULAR NEUROBIOLOGY, 2017, 54(8), 6074-6084.
Authors:  Kosaraju, Jayasankar;  Holsinger, R. M. Damian;  Guo, Lixia;  Tam, Kin Yip
Favorite | TC[WOS]:80 TC[Scopus]:84  IF:4.6/4.7 | Submit date:2018/10/31
Glucagon-like Peptide-1  Glucose-dependent Insulinotropic Polypeptide  Amyloid Beta  Tau Phosphorylation  Neuroinflammation  
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease Journal article
Kosaraju, J., Holsinger, D., Guo, L., Tam, K. Y.. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease[J]. Molecular Neurobiology, 2016, ---.
Authors:  Kosaraju, J.;  Holsinger, D.;  Guo, L.;  Tam, K. Y.
Favorite | TC[WOS]:80 TC[Scopus]:84  IF:4.6/4.7 | Submit date:2022/07/28
Glucagon-like Peptide-1  Glucose-dependent Insulinotropic Polypeptide  Amyloid Beta  Tau Phosphorylation  Neuroinflammation  
Chemical and physical approaches for the treatment of Alzheimer's disease Journal article
Li,Jing, Zhou,Wei, Wu,Xiaoli, Tam,Kin. Chemical and physical approaches for the treatment of Alzheimer's disease[J]. ADMET and DMPK, 2015, 3(3), 216-234.
Authors:  Li,Jing;  Zhou,Wei;  Wu,Xiaoli;  Tam,Kin
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.4/2.8 | Submit date:2021/03/04
Alzheimer's Disease  Deep Brain Stimulation  Neurobiological Pathogenesis  Pharmacological Strategies  Tau Protein  Β-amyloid Peptide  
Chemical and Physical Approaches for the Treatment of Alzheimer's Disease Journal article
Jing Li, WeiZhou, Xiaoli Wu, KinTam. Chemical and Physical Approaches for the Treatment of Alzheimer's Disease[J]. ADMET & DMPK, 2015, 3(3), 216-234.
Authors:  Jing Li;  WeiZhou;  Xiaoli Wu;  KinTam
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.4/2.8 | Submit date:2019/01/07
Alzheimer’s Disease  Β-amyloid Peptide  Tau Protein  Pharmacological Strategies  Deep Brain Stimulation  Neurobiological Pathogenesis  
Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2 Journal article
Chen M., Zhou H., Cheng N., Qian F., Ye R.D.. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2[J]. Immunobiology, 2014, 219(12), 916-923.
Authors:  Chen M.;  Zhou H.;  Cheng N.;  Qian F.;  Ye R.D.
Favorite | TC[WOS]:46 TC[Scopus]:47 | Submit date:2018/11/07
Formyl Peptide Receptors  Inflammation  Innate Immunity  Polymorphism  Serum Amyloid a  Toll-like Receptors